Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coronavirus Disease-2019 (COVID-19)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05097677
What this trial is testing

Follow-up of Covid-19 Long Term Sequelae

Who this might be right for
COVID-19 PneumoniaCOVID-19 Respiratory InfectionCOVID-19 Acute Bronchitis+15 more
Azienda Ospedaliera Universitaria Integrata Verona 7,599
Not applicableUnknownNCT04310228
What this trial is testing

Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019

Who this might be right for
COVID-19
Peking University First Hospital 150
Large-scale testing (Phase 3)WithdrawnNCT04848467
What this trial is testing

COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older

Who this might be right for
SARS-CoV-2 InfectionCoronavirus Disease 2019 (COVID-19)
Bayer
Not applicableUnknownNCT04334265
What this trial is testing

Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019

Who this might be right for
COVID-19
Peking University First Hospital 750
Not applicableStudy completedNCT04588363
What this trial is testing

COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Multisystem Inflammatory Syndrome in Children (MIS-C)Coronavirus Disease 2019 (COVID-19)
National Institute of Allergy and Infectious Diseases (NIAID) 244
Testing effectiveness (Phase 2)Ended earlyNCT04442230
What this trial is testing

NasoVAX in Patients With Early Coronavirus Infectious Disease 2019 (COVID-19)

Who this might be right for
Coronavirus Infection
Altimmune, Inc. 48
Large-scale testing (Phase 3)Study completedNCT04939428
What this trial is testing

Study of MK-4482 for Prevention of Coronavirus Disease 2019 (COVID-19) in Adults (MK-4482-013)

Who this might be right for
Coronavirus Disease (COVID-19)
Merck Sharp & Dohme LLC 2,441
Testing effectiveness (Phase 2)Study completedNCT04537949
What this trial is testing

A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults

Who this might be right for
Covid-19Protection Against COVID-19
BioNTech SE 96
Not applicableStudy completedNCT05209178
What this trial is testing

Diagnostic Accuracy of Self-sampling Versus Healthcare Sampling for Coronavirus-Disease-2019 Detection.

Who this might be right for
COVID-19 Pandemic
Rigshospitalet, Denmark 3,070
Testing effectiveness (Phase 2)UnknownNCT04900415
What this trial is testing

Olfactory and Neurosensory Rehabilitation in COVID-19-related Olfactory Dysfunction

Who this might be right for
Coronavirus Disease 2019
Ivan FN Hung MD 25
Testing effectiveness (Phase 2)WithdrawnNCT05085574
What this trial is testing

Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)

Who this might be right for
2019 Novel Coronavirus Disease2019 Novel Coronavirus Infection2019-nCoV Disease+9 more
Leidos Life Sciences
Testing effectiveness (Phase 2)Study completedNCT04414618
What this trial is testing

Opaganib in Coronavirus Disease 2019 Pneumonia

Who this might be right for
Coronavirus Infections
RedHill Biopharma Limited 42
Testing effectiveness (Phase 2)Study completedNCT04539262
What this trial is testing

Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation

Who this might be right for
COVID-19
Gilead Sciences 156
Not applicableStudy completedNCT04719182
What this trial is testing

Practice of Adjunctive Treatments in Intensive Care Unit Patients With COVID-19

Who this might be right for
Covid19PneumoniaThrombosis+3 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 1,011
Not applicableNo Longer AvailableNCT04802083
What this trial is testing

COVID-19 Soliris Expanded Access Protocol

Who this might be right for
Covid19
Alexion Pharmaceuticals, Inc.
Not applicableNo Longer AvailableNCT04302766
What this trial is testing

Expanded Access Remdesivir (RDV; GS-5734™)

Who this might be right for
Coronavirus Disease 2019
U.S. Army Medical Research and Development Command
Testing effectiveness (Phase 2)Study completedNCT05184062
What this trial is testing

Evaluate the Safety and Tolerability of AZD7442 in Chinese Adults

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
AstraZeneca 272
Testing effectiveness (Phase 2)Study completedNCT04345653
What this trial is testing

Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers

Who this might be right for
Covid19
Hackensack Meridian Health 48
Not applicableStudy completedNCT04927845
What this trial is testing

StriveWeekly Online Mental Health Trial Post-pandemic

Who this might be right for
AnxietyDepressive SymptomsStress, Emotional
Harvard University 538
Testing effectiveness (Phase 2)Study completedNCT04348500
What this trial is testing

Clazakizumab (Anti-Interleukin 6 (IL-6) Monoclonal) Compared to Placebo for Coronavirus Disease 2019 (COVID-19)

Who this might be right for
COVID-19
Cedars-Sinai Medical Center 17
Next Page